Literature DB >> 20505333

Eph receptor and mTOR pathway crosstalk: implications for cancer.

Mustafa Sahin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20505333      PMCID: PMC3096731          DOI: 10.4161/cc.9.11.11925

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  11 in total

Review 1.  Eph receptors and ephrin ligands. essential mediators of vascular development.

Authors:  R H Adams; R Klein
Journal:  Trends Cardiovasc Med       Date:  2000-07       Impact factor: 6.677

2.  A novel putative tyrosine kinase receptor encoded by the eph gene.

Authors:  H Hirai; Y Maru; K Hagiwara; J Nishida; F Takaku
Journal:  Science       Date:  1987-12-18       Impact factor: 47.728

3.  Overexpression confers an oncogenic potential upon the eph gene.

Authors:  Y Maru; H Hirai; F Takaku
Journal:  Oncogene       Date:  1990-03       Impact factor: 9.867

4.  Somatic mutations of the protein kinase gene family in human lung cancer.

Authors:  Helen Davies; Chris Hunter; Raffaella Smith; Philip Stephens; Chris Greenman; Graham Bignell; Jon Teague; Adam Butler; Sarah Edkins; Claire Stevens; Adrian Parker; Sarah O'Meara; Tim Avis; Syd Barthorpe; Lisa Brackenbury; Gemma Buck; Jody Clements; Jennifer Cole; Ed Dicks; Ken Edwards; Simon Forbes; Matthew Gorton; Kristian Gray; Kelly Halliday; Rachel Harrison; Katy Hills; Jonathon Hinton; David Jones; Vivienne Kosmidou; Ross Laman; Richard Lugg; Andrew Menzies; Janet Perry; Robert Petty; Keiran Raine; Rebecca Shepherd; Alexandra Small; Helen Solomon; Yvonne Stephens; Calli Tofts; Jennifer Varian; Anthony Webb; Sofie West; Sara Widaa; Andrew Yates; Francis Brasseur; Colin S Cooper; Adrienne M Flanagan; Anthony Green; Maggie Knowles; Suet Y Leung; Leendert H J Looijenga; Bruce Malkowicz; Marco A Pierotti; Bin T Teh; Siu T Yuen; Sunil R Lakhani; Douglas F Easton; Barbara L Weber; Peter Goldstraw; Andrew G Nicholson; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Cancer Res       Date:  2005-09-01       Impact factor: 12.701

Review 5.  Mechanisms of translational deregulation in human tumors and therapeutic intervention strategies.

Authors:  B Bilanges; D Stokoe
Journal:  Oncogene       Date:  2007-04-02       Impact factor: 9.867

6.  Eph receptors and Ephrins in cancer: common themes and controversies.

Authors:  Jin Chen; Guanglei Zhuang; Leslie Frieden; Waldemar Debinski
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

Review 7.  PI3K pathway alterations in cancer: variations on a theme.

Authors:  T L Yuan; L C Cantley
Journal:  Oncogene       Date:  2008-09-18       Impact factor: 9.867

8.  A role for C. elegans Eph RTK signaling in PTEN regulation.

Authors:  Sarah Brisbin; Jun Liu; Jeff Boudreau; Jimmy Peng; Marie Evangelista; Ian Chin-Sang
Journal:  Dev Cell       Date:  2009-10       Impact factor: 12.270

9.  Somatic mutations affect key pathways in lung adenocarcinoma.

Authors:  Li Ding; Gad Getz; David A Wheeler; Elaine R Mardis; Michael D McLellan; Kristian Cibulskis; Carrie Sougnez; Heidi Greulich; Donna M Muzny; Margaret B Morgan; Lucinda Fulton; Robert S Fulton; Qunyuan Zhang; Michael C Wendl; Michael S Lawrence; David E Larson; Ken Chen; David J Dooling; Aniko Sabo; Alicia C Hawes; Hua Shen; Shalini N Jhangiani; Lora R Lewis; Otis Hall; Yiming Zhu; Tittu Mathew; Yanru Ren; Jiqiang Yao; Steven E Scherer; Kerstin Clerc; Ginger A Metcalf; Brian Ng; Aleksandar Milosavljevic; Manuel L Gonzalez-Garay; John R Osborne; Rick Meyer; Xiaoqi Shi; Yuzhu Tang; Daniel C Koboldt; Ling Lin; Rachel Abbott; Tracie L Miner; Craig Pohl; Ginger Fewell; Carrie Haipek; Heather Schmidt; Brian H Dunford-Shore; Aldi Kraja; Seth D Crosby; Christopher S Sawyer; Tammi Vickery; Sacha Sander; Jody Robinson; Wendy Winckler; Jennifer Baldwin; Lucian R Chirieac; Amit Dutt; Tim Fennell; Megan Hanna; Bruce E Johnson; Robert C Onofrio; Roman K Thomas; Giovanni Tonon; Barbara A Weir; Xiaojun Zhao; Liuda Ziaugra; Michael C Zody; Thomas Giordano; Mark B Orringer; Jack A Roth; Margaret R Spitz; Ignacio I Wistuba; Bradley Ozenberger; Peter J Good; Andrew C Chang; David G Beer; Mark A Watson; Marc Ladanyi; Stephen Broderick; Akihiko Yoshizawa; William D Travis; William Pao; Michael A Province; George M Weinstock; Harold E Varmus; Stacey B Gabriel; Eric S Lander; Richard A Gibbs; Matthew Meyerson; Richard K Wilson
Journal:  Nature       Date:  2008-10-23       Impact factor: 49.962

10.  Tsc2-Rheb signaling regulates EphA-mediated axon guidance.

Authors:  Duyu Nie; Alessia Di Nardo; Juliette M Han; Hasani Baharanyi; Ioannis Kramvis; Thanhthao Huynh; Sandra Dabora; Simone Codeluppi; Pier Paolo Pandolfi; Elena B Pasquale; Mustafa Sahin
Journal:  Nat Neurosci       Date:  2010-01-10       Impact factor: 24.884

View more
  5 in total

Review 1.  Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response.

Authors:  James A McCubrey; Linda S Steelman; William H Chappell; Stephen L Abrams; Giuseppe Montalto; Melchiorre Cervello; Ferdinando Nicoletti; Paolo Fagone; Grazia Malaponte; Maria C Mazzarino; Saverio Candido; Massimo Libra; Jörg Bäsecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Michele Milella; Agostino Tafuri; Lucio Cocco; Camilla Evangelisti; Francesca Chiarini; Alberto M Martelli
Journal:  Oncotarget       Date:  2012-09

2.  Mechanistic or mammalian target of rapamycin (mTOR) may determine robustness in young male mice at the cost of accelerated aging.

Authors:  Olga V Leontieva; Geraldine M Paszkiewicz; Mikhail V Blagosklonny
Journal:  Aging (Albany NY)       Date:  2012-12       Impact factor: 5.682

Review 3.  Advances in targeting signal transduction pathways.

Authors:  James A McCubrey; Linda S Steelman; William H Chappell; Lin Sun; Nicole M Davis; Stephen L Abrams; Richard A Franklin; Lucio Cocco; Camilla Evangelisti; Francesca Chiarini; Alberto M Martelli; Massimo Libra; Saverio Candido; Giovanni Ligresti; Grazia Malaponte; Maria C Mazzarino; Paolo Fagone; Marco Donia; Ferdinando Nicoletti; Jerry Polesel; Renato Talamini; Jörg Bäsecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Michele Michele; Agostino Tafuri; Joanna Dulińska-Litewka; Piotr Laidler; Antonio B D'Assoro; Lyudmyla Drobot; Drobot Umezawa; Giuseppe Montalto; Melchiorre Cervello; Zoya N Demidenko
Journal:  Oncotarget       Date:  2012-12

Review 4.  The role of EPH receptors in cancer-related epithelial-mesenchymal transition.

Authors:  Rui-Xin Li; Zi-Hua Chen; Zhi-Kang Chen
Journal:  Chin J Cancer       Date:  2013-10-09

5.  EphA1 activation promotes the homing of endothelial progenitor cells to hepatocellular carcinoma for tumor neovascularization through the SDF-1/CXCR4 signaling pathway.

Authors:  Yi Wang; Haitao Yu; Yunfeng Shan; Chonglin Tao; Fang Wu; Zhengping Yu; Pengyi Guo; Jianfei Huang; Junjian Li; Qiandong Zhu; Fuxiang Yu; Qitong Song; Hongqi Shi; Mengtao Zhou; Gang Chen
Journal:  J Exp Clin Cancer Res       Date:  2016-04-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.